CARA
Cara Therapeutics Inc
Price:  
4.65 
USD
Volume:  
11,265.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA WACC - Weighted Average Cost of Capital

The WACC of Cara Therapeutics Inc (CARA) is 5.9%.

The Cost of Equity of Cara Therapeutics Inc (CARA) is 8.05%.
The Cost of Debt of Cara Therapeutics Inc (CARA) is 5.00%.

Range Selected
Cost of equity 5.50% - 10.60% 8.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 7.1% 5.9%
WACC

CARA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.36 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 10.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 7.1%
Selected WACC 5.9%